Trial Details
Not recruitingBasic Information
| Clinical ID | c3158 |
|---|---|
| Identifier | NCT01802073 |
| Trial Title | Treatment of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Primary Sclerosing Cholangitis |
| Interventions | Drug: Oral Vancomycin |
Participant Information
| Sponsor | Stanford University |
|---|---|
| City | - |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | 2018-09-21 |
| Completion Date | - |